Therapy News and Research

RSS

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Arteriocyte, a leading clinical stage biotechnology company developing cellular based therapies to treat human diseases, announced today the successful award of another grant by the National Institute of Health for the use of the NANEX platform in Hematopoietic Reconstitution Using Ex Vivo Expanded Umbilical Cord Blood CD34+ Stem Cells.

22 Aug 2012

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

I consider myself to be a fortunate person. I have a good education, a great job and excellent health insurance. I am a baby boomer who has aged reasonably well and can look forward to a fairly comfortable retirement. I am also fortunate because I was diagnosed with hepatitis C by a proactive and knowledgeable doctor in the late 1990s and had the opportunity to be treated and cured. The odds are that if I had not been diagnosed and treated, I would be on a liver transplant list right now, have liver cancer or even be dead from this disease.

22 Aug 2012

Coronary artery calcium tool proves effective in detecting risk of cardiovascular disease

Heart calcium scans are far superior to other assessment tools in predicting the development of cardiovascular disease in individuals currently classified at intermediate risk by their doctors, according to researchers at Wake Forest Baptist Medical Center.

22 Aug 2012

Mof protein plays a key role in epigenetics of stem cells

How do stem cells preserve their ability to become any type of cell in the body? And how do they "decide" to give up that magical state and start specializing? If researchers could answer these questions, our ability to harness stem cells to treat disease could explode. Now, a University of Michigan Medical School team has published a key discovery that could help that goal become reality.

22 Aug 2012

Endovascular brachytherapy may safely and effectively treat femoropopliteal in-stent stenosis

Placement of an endovascular stent has become a common procedure to successfully reopen blocked arteries. Even so, the treated vessel may once again narrow (restenosis), restricting blood flow. In the femoral and popliteal arteries in the leg, the use of nitinol stents magnifies this problem. About 20 to 40 percent of these stent patients experience restenosis 2 years after angioplasty. Now, an improved radiation technique may provide a safe and effective solution.

22 Aug 2012

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Oxygen Biotherapeutics, Inc., announced today that recent research conducted by its partner, Aurum Biosciences, Glasgow, Scotland, has shown that Oxycyte, OBI's proprietary perfluorocarbon-based intravenous emulsion, improves imaging of the penumbra following acute ischemic stroke in a rat model.

22 Aug 2012

Research explores impact of radiotherapy in older women with low risk of breast cancer recurrence

A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions.

22 Aug 2012

GM-CSF depletion suppresses pain in people with arthritis-related conditions

The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation.

22 Aug 2012

Stem-cell therapy holds promise for postinjury arthritis prevention

A novel stem-cell treatment may hold the key to treating osteoarthritis triggered by joint injury, suggest results from an animal study.

21 Aug 2012

CKD may raise stroke, bleeding risk in AF patients

Danish study results show that the presence of chronic kidney disease appears to raise the risk for stroke, systemic thromboembolism, and bleeding among patients with atrial fibrillation.

21 Aug 2012

Gene therapy applied to peripheral arterial disease

Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.

21 Aug 2012

Innovative Therapies forum focuses on topics across wound care settings, surgical disciplines

Modern Negative Pressure Wound Therapy (NPWT) has been in practice since the late 1970's when plastic surgeon Dr. Paul Svedman began treating patients. It is estimated that over half a million patients in the United States receive NPWT every year, but that millions more would benefit from the therapy if it were more accessible.

21 Aug 2012

New silicon chips help identify patients with lupus

Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon chips normally used in computer microprocessors.

21 Aug 2012

Bile duct cancer chosen as next indication for PCI Biotech

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has chosen bileduct cancer as the next indication for the use of its PCI (photochemical internalisation) localised cancer therapy. In this indication PCI Biotech’s proprietary photosensitiser Amphinex® will be used in combination with the generic cytotoxic agent gemcitabine. The aim is to start the clinical Proof of Concept study within end of 1H 2013.

21 Aug 2012

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits the Kv1.3 potassium ion channel.

21 Aug 2012

UCLA Medical Center receives platinum award for outstanding heart attack care

Ronald Reagan UCLA Medical Center has received an award for outstanding heart attack care from the American College of Cardiology Foundation called the NCDR ACTION Registry-GWTG Platinum Performance Achievement Award for 2012.

21 Aug 2012

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

21 Aug 2012

Therapy News and Research

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

Coronary artery calcium tool proves effective in detecting risk of cardiovascular disease

Mof protein plays a key role in epigenetics of stem cells

Endovascular brachytherapy may safely and effectively treat femoropopliteal in-stent stenosis

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Research explores impact of radiotherapy in older women with low risk of breast cancer recurrence

GM-CSF depletion suppresses pain in people with arthritis-related conditions

Stem-cell therapy holds promise for postinjury arthritis prevention

CKD may raise stroke, bleeding risk in AF patients

Gene therapy applied to peripheral arterial disease

Innovative Therapies forum focuses on topics across wound care settings, surgical disciplines

New silicon chips help identify patients with lupus

Bile duct cancer chosen as next indication for PCI Biotech

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

UCLA Medical Center receives platinum award for outstanding heart attack care

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

New tool reveals surprising clues about how cancer cells respond to therapy

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

National Jewish Health, BWH to receive NHLBI grant for second phase of COPDGene project

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News